The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Contraceptive Market Research Report 2024
Synopsis
The global Oral Contraceptive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Contraceptive.
Report Scope
The Oral Contraceptive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Contraceptive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
Segment by Type
Combination
Progestin Only
Others
Segment by Application
Male
Female
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Contraceptive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Contraceptive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Contraceptive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Contraceptive.
Report Scope
The Oral Contraceptive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Contraceptive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
Segment by Type
Combination
Progestin Only
Others
Segment by Application
Male
Female
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Contraceptive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Contraceptive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Contraceptive Market Overview
1.1 Product Overview and Scope of Oral Contraceptive
1.2 Oral Contraceptive Segment by Type
1.2.1 Global Oral Contraceptive Market Value Comparison by Type (2024-2030)
1.2.2 Combination
1.2.3 Progestin Only
1.2.4 Others
1.3 Oral Contraceptive Segment by Application
1.3.1 Global Oral Contraceptive Market Value by Application: (2024-2030)
1.3.2 Male
1.3.3 Female
1.4 Global Oral Contraceptive Market Size Estimates and Forecasts
1.4.1 Global Oral Contraceptive Revenue 2019-2030
1.4.2 Global Oral Contraceptive Sales 2019-2030
1.4.3 Global Oral Contraceptive Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Contraceptive Market Competition by Manufacturers
2.1 Global Oral Contraceptive Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Contraceptive Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Contraceptive Average Price by Manufacturers (2019-2024)
2.4 Global Oral Contraceptive Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Contraceptive, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Contraceptive, Product Type & Application
2.7 Oral Contraceptive Market Competitive Situation and Trends
2.7.1 Oral Contraceptive Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Contraceptive Players Market Share by Revenue
2.7.3 Global Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Contraceptive Retrospective Market Scenario by Region
3.1 Global Oral Contraceptive Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Contraceptive Global Oral Contraceptive Sales by Region: 2019-2030
3.2.1 Global Oral Contraceptive Sales by Region: 2019-2024
3.2.2 Global Oral Contraceptive Sales by Region: 2025-2030
3.3 Global Oral Contraceptive Global Oral Contraceptive Revenue by Region: 2019-2030
3.3.1 Global Oral Contraceptive Revenue by Region: 2019-2024
3.3.2 Global Oral Contraceptive Revenue by Region: 2025-2030
3.4 North America Oral Contraceptive Market Facts & Figures by Country
3.4.1 North America Oral Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Contraceptive Sales by Country (2019-2030)
3.4.3 North America Oral Contraceptive Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Contraceptive Market Facts & Figures by Country
3.5.1 Europe Oral Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Contraceptive Sales by Country (2019-2030)
3.5.3 Europe Oral Contraceptive Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Contraceptive Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Contraceptive Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Contraceptive Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Contraceptive Market Facts & Figures by Country
3.7.1 Latin America Oral Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Contraceptive Sales by Country (2019-2030)
3.7.3 Latin America Oral Contraceptive Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Contraceptive Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Contraceptive Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Contraceptive Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Contraceptive Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Contraceptive Sales by Type (2019-2030)
4.1.1 Global Oral Contraceptive Sales by Type (2019-2024)
4.1.2 Global Oral Contraceptive Sales by Type (2025-2030)
4.1.3 Global Oral Contraceptive Sales Market Share by Type (2019-2030)
4.2 Global Oral Contraceptive Revenue by Type (2019-2030)
4.2.1 Global Oral Contraceptive Revenue by Type (2019-2024)
4.2.2 Global Oral Contraceptive Revenue by Type (2025-2030)
4.2.3 Global Oral Contraceptive Revenue Market Share by Type (2019-2030)
4.3 Global Oral Contraceptive Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Contraceptive Sales by Application (2019-2030)
5.1.1 Global Oral Contraceptive Sales by Application (2019-2024)
5.1.2 Global Oral Contraceptive Sales by Application (2025-2030)
5.1.3 Global Oral Contraceptive Sales Market Share by Application (2019-2030)
5.2 Global Oral Contraceptive Revenue by Application (2019-2030)
5.2.1 Global Oral Contraceptive Revenue by Application (2019-2024)
5.2.2 Global Oral Contraceptive Revenue by Application (2025-2030)
5.2.3 Global Oral Contraceptive Revenue Market Share by Application (2019-2030)
5.3 Global Oral Contraceptive Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer, Inc.
6.1.1 Pfizer, Inc. Corporation Information
6.1.2 Pfizer, Inc. Description and Business Overview
6.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer, Inc. Oral Contraceptive Product Portfolio
6.1.5 Pfizer, Inc. Recent Developments/Updates
6.2 Bayer AG
6.2.1 Bayer AG Corporation Information
6.2.2 Bayer AG Description and Business Overview
6.2.3 Bayer AG Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer AG Oral Contraceptive Product Portfolio
6.2.5 Bayer AG Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc. Oral Contraceptive Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Janssen Global Services, LLC
6.4.1 Janssen Global Services, LLC Corporation Information
6.4.2 Janssen Global Services, LLC Description and Business Overview
6.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Global Services, LLC Oral Contraceptive Product Portfolio
6.4.5 Janssen Global Services, LLC Recent Developments/Updates
6.5 Mankind Pharma Ltd.
6.5.1 Mankind Pharma Ltd. Corporation Information
6.5.2 Mankind Pharma Ltd. Description and Business Overview
6.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mankind Pharma Ltd. Oral Contraceptive Product Portfolio
6.5.5 Mankind Pharma Ltd. Recent Developments/Updates
6.6 Teva Pharmaceutical Industries Ltd
6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Portfolio
6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.7 Allergan, plc (Actavis)
6.6.1 Allergan, plc (Actavis) Corporation Information
6.6.2 Allergan, plc (Actavis) Description and Business Overview
6.6.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan, plc (Actavis) Oral Contraceptive Product Portfolio
6.7.5 Allergan, plc (Actavis) Recent Developments/Updates
6.8 Piramal Enterprises Ltd.
6.8.1 Piramal Enterprises Ltd. Corporation Information
6.8.2 Piramal Enterprises Ltd. Description and Business Overview
6.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Piramal Enterprises Ltd. Oral Contraceptive Product Portfolio
6.8.5 Piramal Enterprises Ltd. Recent Developments/Updates
6.9 Beijing Zizhu Pharm
6.9.1 Beijing Zizhu Pharm Corporation Information
6.9.2 Beijing Zizhu Pharm Description and Business Overview
6.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Zizhu Pharm Oral Contraceptive Product Portfolio
6.9.5 Beijing Zizhu Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Contraceptive Industry Chain Analysis
7.2 Oral Contraceptive Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Contraceptive Production Mode & Process
7.4 Oral Contraceptive Sales and Marketing
7.4.1 Oral Contraceptive Sales Channels
7.4.2 Oral Contraceptive Distributors
7.5 Oral Contraceptive Customers
8 Oral Contraceptive Market Dynamics
8.1 Oral Contraceptive Industry Trends
8.2 Oral Contraceptive Market Drivers
8.3 Oral Contraceptive Market Challenges
8.4 Oral Contraceptive Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Oral Contraceptive Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Contraceptive Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Contraceptive Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Contraceptive Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Contraceptive Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Contraceptive Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Contraceptive Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Contraceptive Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Contraceptive, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Contraceptive, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Contraceptive, Product Type & Application
Table 12. Global Key Manufacturers of Oral Contraceptive, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Contraceptive as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Contraceptive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Contraceptive Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Contraceptive Sales Market Share by Region (2019-2024)
Table 19. Global Oral Contraceptive Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Contraceptive Sales Market Share by Region (2025-2030)
Table 21. Global Oral Contraceptive Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Contraceptive Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Contraceptive Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Contraceptive Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Contraceptive Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Contraceptive Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Contraceptive Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Contraceptive Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Contraceptive Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Contraceptive Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Contraceptive Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Contraceptive Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Contraceptive Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Contraceptive Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Contraceptive Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Contraceptive Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Contraceptive Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Contraceptive Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Contraceptive Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Contraceptive Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Contraceptive Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Contraceptive Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Contraceptive Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Contraceptive Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Contraceptive Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Contraceptive Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Contraceptive Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Contraceptive Sales Market Share by Type (2019-2024)
Table 53. Global Oral Contraceptive Sales Market Share by Type (2025-2030)
Table 54. Global Oral Contraceptive Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Contraceptive Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Contraceptive Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Contraceptive Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Contraceptive Price (USD/Unit) by Type (2019-2024)
Table 59. Global Oral Contraceptive Price (USD/Unit) by Type (2025-2030)
Table 60. Global Oral Contraceptive Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Contraceptive Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Contraceptive Sales Market Share by Application (2019-2024)
Table 63. Global Oral Contraceptive Sales Market Share by Application (2025-2030)
Table 64. Global Oral Contraceptive Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Contraceptive Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Contraceptive Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Contraceptive Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Contraceptive Price (USD/Unit) by Application (2019-2024)
Table 69. Global Oral Contraceptive Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer, Inc. Corporation Information
Table 71. Pfizer, Inc. Description and Business Overview
Table 72. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer, Inc. Oral Contraceptive Product
Table 74. Pfizer, Inc. Recent Developments/Updates
Table 75. Bayer AG Corporation Information
Table 76. Bayer AG Description and Business Overview
Table 77. Bayer AG Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Bayer AG Oral Contraceptive Product
Table 79. Bayer AG Recent Developments/Updates
Table 80. Merck & Co., Inc. Corporation Information
Table 81. Merck & Co., Inc. Description and Business Overview
Table 82. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Merck & Co., Inc. Oral Contraceptive Product
Table 84. Merck & Co., Inc. Recent Developments/Updates
Table 85. Janssen Global Services, LLC Corporation Information
Table 86. Janssen Global Services, LLC Description and Business Overview
Table 87. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Janssen Global Services, LLC Oral Contraceptive Product
Table 89. Janssen Global Services, LLC Recent Developments/Updates
Table 90. Mankind Pharma Ltd. Corporation Information
Table 91. Mankind Pharma Ltd. Description and Business Overview
Table 92. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Mankind Pharma Ltd. Oral Contraceptive Product
Table 94. Mankind Pharma Ltd. Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Allergan, plc (Actavis) Corporation Information
Table 101. Allergan, plc (Actavis) Description and Business Overview
Table 102. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Allergan, plc (Actavis) Oral Contraceptive Product
Table 104. Allergan, plc (Actavis) Recent Developments/Updates
Table 105. Piramal Enterprises Ltd. Corporation Information
Table 106. Piramal Enterprises Ltd. Description and Business Overview
Table 107. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Piramal Enterprises Ltd. Oral Contraceptive Product
Table 109. Piramal Enterprises Ltd. Recent Developments/Updates
Table 110. Beijing Zizhu Pharm Corporation Information
Table 111. Beijing Zizhu Pharm Description and Business Overview
Table 112. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Beijing Zizhu Pharm Oral Contraceptive Product
Table 114. Beijing Zizhu Pharm Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Oral Contraceptive Distributors List
Table 118. Oral Contraceptive Customers List
Table 119. Oral Contraceptive Market Trends
Table 120. Oral Contraceptive Market Drivers
Table 121. Oral Contraceptive Market Challenges
Table 122. Oral Contraceptive Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Contraceptive
Figure 2. Global Oral Contraceptive Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Contraceptive Market Share by Type in 2023 & 2030
Figure 4. Combination Product Picture
Figure 5. Progestin Only Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Contraceptive Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oral Contraceptive Market Share by Application in 2023 & 2030
Figure 9. Male
Figure 10. Female
Figure 11. Global Oral Contraceptive Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Contraceptive Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oral Contraceptive Sales (2019-2030) & (K Units)
Figure 14. Global Oral Contraceptive Average Price (USD/Unit) & (2019-2030)
Figure 15. Oral Contraceptive Report Years Considered
Figure 16. Oral Contraceptive Sales Share by Manufacturers in 2023
Figure 17. Global Oral Contraceptive Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oral Contraceptive Players: Market Share by Revenue in 2023
Figure 19. Oral Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oral Contraceptive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oral Contraceptive Sales Market Share by Country (2019-2030)
Figure 22. North America Oral Contraceptive Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oral Contraceptive Sales Market Share by Country (2019-2030)
Figure 26. Europe Oral Contraceptive Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oral Contraceptive Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oral Contraceptive Revenue Market Share by Region (2019-2030)
Figure 34. China Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Oral Contraceptive Sales Market Share by Country (2019-2030)
Figure 45. Latin America Oral Contraceptive Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Oral Contraceptive Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Oral Contraceptive Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Oral Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Oral Contraceptive by Type (2019-2030)
Figure 55. Global Revenue Market Share of Oral Contraceptive by Type (2019-2030)
Figure 56. Global Oral Contraceptive Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Oral Contraceptive by Application (2019-2030)
Figure 58. Global Revenue Market Share of Oral Contraceptive by Application (2019-2030)
Figure 59. Global Oral Contraceptive Price (USD/Unit) by Application (2019-2030)
Figure 60. Oral Contraceptive Value Chain
Figure 61. Oral Contraceptive Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
